2019
DOI: 10.1111/apt.15384
|View full text |Cite
|
Sign up to set email alerts
|

Letter: when to withhold anti‐TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out

Abstract: Linked ContentThis article is linked to Lin et al papers. To view these articles, visit https://doi.org/10.1111/apt.15184 and https://doi.org/10.1111/apt.15398.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…Authors' reply EDITORS, We read with great interest the letter by Gates et al regarding the timing of withholding anti-TNF agents before abdominal surgery in patients with Crohn's disease (CD). 1 There might be some misunderstanding. We do suggest stopping anti-TNF agents before surgery, but we are not sure of the best timing.…”
mentioning
confidence: 99%
“…Authors' reply EDITORS, We read with great interest the letter by Gates et al regarding the timing of withholding anti-TNF agents before abdominal surgery in patients with Crohn's disease (CD). 1 There might be some misunderstanding. We do suggest stopping anti-TNF agents before surgery, but we are not sure of the best timing.…”
mentioning
confidence: 99%